SenesTech, Inc. - Common Stock, par value $0.001 per share (SNES)

CUSIP: 81720R604

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
5,301,399
Total 13F shares
98,538
Share change
+90,435
Total reported value
$501,557
Price per share
$5.09
Number of holders
8
Value change
+$460,790
Number of buys
7
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 81720R604?
CUSIP 81720R604 identifies SNES - SenesTech, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of SNES - SenesTech, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
PFS CAP MGT CO
13D/G
10%
340,000
$1,683,000 +$1,234,990 30 Jun 2025
Lind Global Fund II LP
13D/G
4.9%
93,370
$208,215 -$41,545 31 Mar 2025
Kenneth S. Siegel
3/4/5
Chief Executive Officer, Director
class O/S missing
150,000
$142,170 17 Feb 2022
Kathleen Claire Kavanagh
3/4/5
Director
class O/S missing
142,668
$135,221 01 Jul 2022
Marc Dumont
3/4/5
Director
class O/S missing
96,218
$91,195 01 Jul 2022
Phillip Nicholas Grandinetti III
3/4/5
Director
class O/S missing
14,672
$45,729 27 Aug 2024
Jamie Bechtel Morrison
3/4/5
Director
class O/S missing
12,090
$41,917 27 Aug 2024
Thomas C. Chesterman
3/4/5
CFO & Treasurer
class O/S missing
24,170
$32,936 27 Aug 2024
Delphine Francois Chiavarini
3/4/5
Director
class O/S missing
26,536
$25,151 26 Jun 2023
Nicole C. Williams
3/4/5
Chief Strategy Officer
class O/S missing
26,500
$25,117 14 Dec 2022
UBS Group AG
13F
Company
0.1%
5,295
$9,584 31 Mar 2025
13F
Kim Patrice Wolin
3/4/5
EVP and Secretary
class O/S missing
10,000
$9,478 17 Feb 2022
OSAIC HOLDINGS, INC.
13F
Company
0.05%
2,800
$5,068 31 Mar 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
8
$14 31 Mar 2025
13F
Joel Lee Fruendt
3/4/5
Chief Executive Officer, Director
class O/S missing
56,396
27 Aug 2024
Joshua Matthew Moss
3/4/5
Director
class O/S missing
8,057
08 Jan 2025

Institutional Holders of SenesTech, Inc. - Common Stock, par value $0.001 per share (SNES) as of Q2 2025

As of 30 Jun 2025, SenesTech, Inc. - Common Stock, par value $0.001 per share (SNES) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 98,538 shares. The largest 8 holders included CORSAIR CAPITAL MANAGEMENT, L.P., JANE STREET GROUP, LLC, GEODE CAPITAL MANAGEMENT, LLC, OSAIC HOLDINGS, INC., MORGAN STANLEY, BANK OF AMERICA CORP /DE/, RAYMOND JAMES FINANCIAL INC, and UBS Group AG. This page lists 8 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
3
Q2 2025 holders
8
Holder diff
5
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .